Clinical Trial Update: A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and pharmacology of subcutaneous CINRYZE with recombinant human hyaluronidase in hereditary angioedema has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Cinryze (C1 esterase inhibitor)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 2 | Status: COMPLETED | Results posted: 2013-01-04